Karmanos Cancer Center — Detroit, Michigan

Karmanos Cancer Center is a clinical research site located in Detroit, Michigan, United States.

Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

Karmanos Cancer Center has participated in 63 clinical trials with 16 currently active.

Therapeutic areas: Cancer, Relapsed Refractory Multiple Myeloma, Breast Cancer.

Sponsors: Eisai Inc., Multiple Myeloma Research Consortium, Marker Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Karmanos Cancer Center?

Karmanos Cancer Center has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Karmanos Cancer Center conducted?

Karmanos Cancer Center has 63 clinical trials on record, with 16 currently active. Their work covers Cancer, Relapsed Refractory Multiple Myeloma, Breast Cancer.

Is Karmanos Cancer Center accredited by Crixeo Health?

Karmanos Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Karmanos Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.